论文部分内容阅读
广西是我国原发性肝癌高发地区之一,肝癌死亡率占全自治区恶性肿瘤死亡率的40％以上。广西医学院外科从1958～1983年共剖腹探查病现确诊为肝癌者601例,能手术切除者243例。其中男200例,女43例,年龄9个月～82岁。按1977年全国肝癌协作组会议制定的标准,单纯型Ⅰ期4例、Ⅱ期162例、Ⅲ期25例,硬化刑Ⅱ期41例、Ⅲ期2例,炎症型Ⅱ期8例、Ⅲ期1例。手术切除率为40.4％(243/601),术后并发症发生率为15.2％(37/243),手术死亡率为8.6％(21/243),手术后随访率为96.8％,术后1、3、5、10年生存率分别为57.2％,30.5％,25.1％、14.7％。文章并就肝癌的早期诊断进行讨论,作者并结合临床实践体会,对肝癌术前、后用化疗配合手术,手术的适应症、手术的切口、手术切除的方法和肝钳切肝等问题提出自己的见解。
Guangxi is one of the regions with high incidence of primary liver cancer in China. The mortality rate of liver cancer accounts for more than 40% of the malignant tumor mortality in the whole region. From 1958 to 1983, Guangxi Medical College had a total of 601 cases of hepatocellular carcinoma and 243 cases of surgical resection. Including 200 males and 43 females, aged 9 months to 82 years old. According to the standards set by the National Hepatoma Collaboration Group Meeting in 1977, there were 4 cases of simple type I, 162 cases of phase II, 25 cases of stage III, 41 cases of stage II sclerosis, 2 cases of stage III, 8 cases of stage II inflammation, and 3 stages of inflammation. 1 case. The surgical resection rate was 40.4% (243/601). The postoperative complication rate was 15.2% (37/243). The operative mortality was 8.6% (21/243). The follow-up rate after surgery was 96.8%. The three-, five-, and 10-year survival rates were 57.2%, 30.5%, 25.1%, and 14.7%, respectively. The article also discussed the early diagnosis of liver cancer, and the author combined with clinical practice experience, put forward their own problems before and after liver cancer chemotherapy combined with surgery, surgical indications, surgical incision, surgical resection and liver clamp liver and other issues Insights.